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A Distributed Model of Carbohydrate Transport and Metabolism
in the Liver during Rest and High-Intensity Exercise
E. CHALHOUB,1 L. XIE,1 V. BALASUBRAMANIAN,1 J. KIM,2 and J. BELOVICH 1
1

Department of Chemical and Biomedical Engineering, Cleveland State University, 2121 Euclid Avenue, Cleveland,
OH 44115-2425, USA and 2Case Western Reserve University, Cleveland, USA

Abstract—A model of reaction and transport in the liver was
developed that describes the metabolite concentration and
reaction ﬂux dynamics separately within the tissue and blood
domains. The blood domain contains equations for convec
tion, axial dispersion, and transport to the surrounding
tissue; and the tissue domain consists of reactions represent
ing key carbohydrate metabolic pathways. The model
includes the metabolic heterogeneity of the liver by incorpo
rating spatial variation of key enzymatic maximal activities.
Simulation results of the overnight fasted, resting state agree
closely with experimental values of overall glucose uptake
and lactate output by the liver. The incorporation of
zonation of glycolytic and gluconeogenic enzyme activities
causes the expected increase in glycolysis and decrease in
gluconeogenesis along the sinusoid length from periportal to
perivenous regions, while ﬂuxes are nearly constant along the
sinusoid length in the absence of enzyme zonation. These
results conﬁrm that transport limitations are not sufﬁcient to
account for the observed tissue heterogeneity of metabolic
ﬂuxes. Model results indicate that changes in arterial
substrate concentrations and hepatic blood ﬂow rate, which
occur in the high-intensity exercise state, are not sufﬁcient to
shift the liver metabolism enough to account for the 5-fold
increase in hepatic glucose production measured during
exercise. Changes in maximal activities, whether caused by
exercise-induced changes in insulin, glucagon, or other
hormones are shown to be needed to achieve the expected
glucose output. This model provides a framework for
evaluating the relative importance to hepatic function of
various phenomenological changes that occur during exer
cise. The model can also be used to assess the potential effect
of metabolic heterogeneity on metabolism.
Keywords—Computer simulation, Modeling, Liver, Carbo
hydrate metabolism.

INTRODUCTION
Mathematical models of the liver can be divided
into two broad categories: lumped models that con
sider the organ as well-mixed, and single-drug elimi
nation models that consider the heterogeneous nature
of the organ. Garﬁnkel22 developed the ﬁrst compre
hensive model of liver metabolism using the lumped
approach and detailed in vitro-based kinetic expres
sions. Other hepatic carbohydrate metabolism models
based on the lumped model approach include that
developed by Refai and Bergman (1976), who simu
lated glycogen metabolism and more recently by Beard
and Qian,5 who developed a thermodynamic con
straint-based model, among others. Numerous others
have developed metabolic models that consider speciﬁc
functions or pathways within the liver, again using the
well-mixed approach. Rowland et al.60 used this
approach to predict the elimination of drugs such as
lignocaine and mepridine. In addition to liver models,
there is a very large body of work on models of com
plex metabolic systems (including other organ systems,
cell lines, and single-celled organisms) that are based
on the well-mixed approach.
While the well-mixed approach may be appropriate
for single-celled organisms and cell lines, it is less
appropriate for organs, such as the liver, that have a
distributed-in-space organization. The human liver is
constructed of about 1,000 lobules, with each lobule
consisting of about a million channels through which
blood ﬂows (the sinusoids), with each sinusoid sur
rounded by a layer of hepatocytes. The sinusoids are
arranged roughly in parallel, and drain into a central
vein. Models that consider this distributed-in-space
nature have represented the liver by a system of par
allel tubes in which blood ﬂows through each tube with
the same velocity. The elimination of drugs such as
ethanol, galactose, and diazepam has been modeled
using this approach (e.g. Saville et al.62). These models
are mathematically simple—they do not include

dispersion and usually consist of a single species mass
balance and single reaction.
Roberts and Rowland proposed a dispersion model
of the liver.59 As in the parallel tube approach, the
dispersion model assumes that the liver is a tubular
reactor. In addition, the model includes axial disper
sion which is based on cumulative effects of radial
variations in velocity, variations in length of the sinu
soid, convective mixing in the ﬂow direction of blood
in the sinusoid, and diffusion. The model was applied
to the drugs antipyrine, carbamazepine, and ligno
caine. The model consists of a partial differential
equation for the drug in one compartment (sinusoid)
and a ﬁrst order elimination rate
Gray and Tam27 have suggested a model that con
siders the liver as a series of compartments connected
together. The model is based on the tanks-in-series
model used by chemical engineers. Each compartment
is considered to be well mixed. The model does not
differentiate the blood from the tissue compartments.
Tsuji et al. 68 developed a liver model consisting of
mass balances for a single species (i.e. drug b-Lactum
antibiotics) in three compartments, representing the
sinusoids, space of Disse and tissue.
Bassingthwaite et al.4 developed a model for capil
lary-tissue exchange that combined both the Krogh’s
cylinder model for the transport of oxygen from the
capillary into tissue, and the dispersion model. The
model is of a single straight capillary surrounded by a
concentric tissue compartment. The model had two
sets of equations, one representing concentration in the
capillary and the other in the tissue. This model was
used to predict the concentration of a metabolite along
the axial direction in a capillary, and along axial and
radial directions in the tissue. This work was extended
to represent parallel multi-capillary systems in King
et al.46 and Deussen and Bassingthwaighte.15
None of these distributed-in-space models consid
ered the complex network of metabolic pathways
found in the liver, nor the unique feature of the liver,
that is, the metabolic heterogeneity or zonation shown
by the hepatocytes. Hepatocytes from the periportal
zone of the liver have diﬀerent enzyme activities from
the perivenous zone.42 It has been shown that the
periportal zone has relatively high gluconeogenesis rate
since the zone is rich in enzyme activities such as glu
cose-6-phosphatase, fructose 1,6 bisphosphatase and
phosphoenolpyruvate carboxykinase, while the peri
venous zone is rich in glycolytic enzyme activities such
as pyruvate kinase and glucokinase. During the
absorptive phase, the perivenous cells take up glucose
from the blood and convert it into glycogen and lac
tate. The lactate is released into the blood stream, and
in combination with lactate released by the gut, is then
absorbed by the periportal cells and converted to gly

cogen through gluconeogenesis. During the fasting
phase, the periportal cells release glucose from the
breakdown of glycogen and through gluconeogenesis,
while the perivenous cells form lactate through glyco
gen breakdown.
We have combined the features of the detailed car
bohydrate metabolism found in the lumped models
with features of the dispersion, Krogh cylinder, and
multi-capillary system approaches in order to represent
carbohydrate metabolism as well as tissue heteroge
neity and axial concentration gradients. The model of
the single sinusoid considers two compartments: the
blood compartment, with convection, axial dispersion,
and transport to the surrounding tissue; and the tissue
compartment, where reactions representing key pro
cesses of glycolysis, gluconeogenesis, glycogenolysis,
tricarboxylic acid cycle, oxidative phosphorylation,
and fatty acid degradation and synthesis take place.
Each reaction is represented by Michaelis–Menten
expressions with modulation by ADP/ATP and/or
NADH/NAD+, as appropriate, using an approach
similar to that by Salem et al.61. The model includes
the metabolic heterogeneity of the liver by incorpo
rating spatial variation of key enzymatic activities. By
means of this model one can predict gradients in
reaction rates in the tissue, and determine whether
these gradients result primarily from concentration
gradients in the sinusoid or from zonation of enzyme
activities. The results from the single sinusoid model
are then scaled-up to provide values for total organ
output ﬂuxes and concentrations which are compared
to experimental data.
This liver model is intended to be included in a
whole-body model being developed by other members
of the research team. One of the goals of the wholebody model development is the integration of physio
logical data related to high-intensity exercise and an
improved understanding of controlling factors under
lying the physiological response to exercise. To this
end, hepatic concentrations and ﬂuxes during the fas
ted, high-intensity exercise state, were calculated using
the model presented here. These simulations allow one
to determine the relative importance of various phys
iological changes that occur during exercise on hepatic
glucose/lactate output, such as the increased arterial
lactate concentration and the changes in enzymatic
activities induced by glucagon secretion.

MODEL DEVELOPMENT
Overall Liver Model
The human liver is known to have 1 million lobules,
with each lobule containing about 1000 sinusoids.

Ci,blood | x=L,j . is the concentration of species i at the
outlet of each sinusoid j (i.e. the central vein). The net
production from the entire liver is given by:

Sinusoid j

Pi ¼

nsin
usoids
X

ð2Þ

pi;j

j

FIGURE 1. Schematic of the lobule structure within the liver.

Each lobule is drained by a central vein, and the output
from all lobules is collected in the hepatic vein. Blood
ﬂows roughly in parallel through all of the approxi
mately 1 billion sinusoids. A schematic of the liver,
which is the basis of the model presented here, is shown
in Fig. 1.
The net production rate of species i in sinusoid j (pij)
is given by a mass balance over the entire sinusoid:
pi;j ¼ vj Axs;j ðCi;blood;j

1
x¼L;j -Ci;blood Þ

ð1Þ

where vj is the blood velocity in sinusoid j, Axs,j is the
cross-sectional area of each sinusoid calculated from
the sinusoid diameter (ds), C¥ i,blood is the concentra
tion of species i in the blood upstream of the sinusoid
(i.e. mixture of the hepatic artery and portal vein), and

All sinusoids are assumed to have the same length
(L), blood velocity (v), and cross-sectional area. The
sinusoid length has been reported to be 0.25–
1 mm.56,51,50 Blood velocity distributions have been
reported to range from 0–400lm/s,51 with means of
69lm/s in mouse and 180lm/s in rat, while Koo and
Liang47 reported velocities of 150–250lm/s in rat. The
sinusoid diameter (ds) is reported at values from 4 to
15 um, with the diameter slightly increasing from
periportal to perivenous ends.50,51,56 The actual values
used in the model (Table 1) were selected from within
the reported ranges, with the criteria that they result in
liver geometry that is consistent with macroscopic
measurements of human liver. Using the equation for
total liver blood ﬂow rate, Q, and assuming that all the
sinusoids have the same length and velocity (i.e.,
vj = v):
Q¼

nsin
usoids
X

vj Axs;j

j

results in Q = 1.47 l/min blood ﬂow (compared to
1.5 l/min as commonly reported), 83% liver mass equal

Table 1. Model parameters.
Variable

Description

Value used in model

Additional information/reference

ds

Diameter of sinusoid

5.7 lm

4 lm (PP) and 5 lm (PP)50; 5.9 lm (PP) and 7.3 lm
(PV) in mice51; 7–15 lm56.
3.6lm (calculated from Goresky et al.,26) 6–12 um
human hepatocyte radius, 2.5–8 um in other tissue
(http://www.bartleby.com/107/pages/page1196.html)
Calculated from Goresky et al. 26.

dt

ded

1
2

of hepatocyte sheet thickness

Endothelial cell thickness +
space of Disse
Sinusoid length

5.5 lm

1.8 lm

9.5 x 10)8 cm3
4.42 x 10)8 cm3

Calculated.

v

Volume of tissue surrounding a
single sinusoid
Volume of blood within a single
sinusoid plus the space of Disse
Velocity of blood in sinusoid

1 mm50; 0.25 mm56; 0.3 mm, estimated
from images51.
Calculated.

183 lm; yields s = 5.4 s

Mean values: 69 lm/s (mouse) and 180 lm/s
(rat), range: 0–400 lm/s51; 150, 250 lm/s, rat47

nsinusoids
Q
DG
DL

Number of sinusoids in the liver
Blood ﬂow rate through liver
Diffusivity of glucose in blood
Diffusivity of lactate in blood

5.23 x 109
1.47 l/min
5.46 x 10)4 cm2/min
7.71 x 10)4 cm2/min

Da,G
Da, L

Dispersion coefﬁcient of glucose
Dispersion coefﬁcient of lactate

5.50 x 10)4 cm2/min
7.74 x 10)4 cm2/min

L
Vtissue
Vblood

1 mm

Renkin58
Calculated using Renkin's model
1.013 x 10)4 x (MW))0.46
Calculated using Eq. (4)
Calculated using Eq. (4)
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to hepatocytes (compared to 80% as commonly
reported), and residence time within a single sinusoid
of 5 s (compared to mean residence time of 4 s24).
The concentration of each species at the outlet of
each sinusoid (Ci,blood | x=L,j) is obtained from the
mass balances comprising the model of the individual
sinusoid, given in the following section.

L

C i, blood

Ci, blood (x,t)

sinusoid

Ci, blood

x=L

endothelial + space of Disse
Ci, tissue (x,t)

tissue)

hepatocytes (tissue)

X

Single Sinusoid Model
Each sinusoid is lined with endothelial cells, which
are separated from the single row of surrounding he
patocytes by the space of Disse (Fig. 2). The endo
thelial cells contain fenestrae, or pores, that permit
dissolved substances in the blood to enter the space of
Disse, but prevent transport of large particles such as
red blood cells.
An idealized view of the sinusoid is used as the basis
for the model (Fig. 3). The liver tissue is represented as
a cylindrical region surrounding the sinusoid with a
constant cross sectional area. The model can be con
sidered to consist of three domains: the sinusoid, the
space of Disse, and the tissue. Goresky et al.26 have
shown through their tracer studies that species con
centrations in the space of Disse equilibrate rapidly
and are nearly equal to the species concentrations
within the sinusoids. Moreover, convective transport
within this region can be considered negligible.
Therefore, mass balances are only written for the
sinusoid and tissue domains, while the concentrations
within the space of Disse are assumed to be equal to
the concentrations at the corresponding axial position
in the sinusoid.

FIGURE 3. Schematic of a single idealized sinusoid as basis
for the model. Large arrows represent the ﬂow of blood within
the sinusoid. Ci,blood is the concentration of species i within
the sinusoid, as function of axial distance and time; Ci,tissue is
the concentration of species i within the tissue, as function of
axial distance and time; L is the length of an average sinusoid;
C¥i,blood is the concentration of species i entering the sinusoid
from the portal artery and hepatic vein.

model,18 which describes the plug ﬂow of a com
pound through a tubular reactor, with slight modiﬁ
cation by including the transport of the species from
blood into the tissue:
@Ci;blood
@Ci;blood
@ 2 Ci;blood
¼ -v
þ Da;i
- Ji;b-t ðx; tÞ
@t
@x
@x2
ð3Þ
where Ci is the concentration of species i, t is time, x is
axial distance along the sinusoid, da,i is the dispersion
coefﬁcient, and Ji,b-t is the transport ﬂux from the
blood into tissue. The kinetics for bi-directional car
rier-mediated transport is given by the simpliﬁed
expression:
Ji;b-t ¼

Governing Equations
The mass balance for each species in the blood
within a single sinusoid is based on the convective
ﬂow of blood through the sinusoid, the dispersion
occurring due to the ﬂow, and the transport of the
metabolite from blood into the hepatocytes. The mass
balance equation is given by Taylor’s axial dispersion

hepatic arteriole
periportal

perivenous
space of Disse
blood (sinusoid)

x

hepatic venule

hepatocytes

portal venule

FIGURE 2. Schematic of a single sinusoid.

Vmaxi ðCi;blood - Ci;tissue Þ
Kmi þ ðCi;blood þ Ci;tissue Þ

The dispersion coeﬃcients were calculated by the Aris–
Taylor’s relation18:
�vd �2
s

Da;i ¼ Di þ

2

48Di

ð4Þ

where di is the diffusion coefﬁcient of species i in blood.
The mass balance of each species in the tissue
includes transport between the blood and tissue and
reaction kinetics. Due to the relatively small tissue
thickness, concentration gradients in the radial direc
tion are neglected. Axial diﬀusion is also neglected. The
tissue here is treated as a set of sub-compartments
connected in parallel to the sinusoid domain, via the
space of Disse domain. Since the concentrations in the
space of Disse equilibrate rapidly with the concentra
tions in the corresponding position within the sinusoid,
the radial ﬂux can be considered to result from the
concentration diﬀerence between each tissue sub-com
partment and the corresponding region of the sinusoid.

Reactions occur inside each tissue sub-compartment,
and each sub-compartment is considered to be wellmixed. The concentration gradient in the tissue is thus
driven by diﬀerent rates of transport into/out of each
tissue sub-compartment, as well as diﬀerent reaction
rates in each sub-compartment. The general mass bal
ance equation for each metabolite i in tissue is then:
@Ci;tissue ðx; tÞ
¼ J0i;b-t ðx; tÞ - Ri ðx; tÞ
@t

ð5Þ

where Ri = rate of reaction of each metabolite within
each tissue sub-compartment.
The transport ﬂux for the tissue equation is divided
by the volume ratio (Vratio) of tissue to blood to make
the units consistent for the two compartments. By
doing this, the units of the transport ﬂux will be with
respect to each compartmental volume:
J0b-t ¼ Jb-t * ð

1
Vratio

Þ

where Vratio ¼ Vtissue =Vblood , Vtissue is the volume of
tissue surrounding a single sinusoid, and Vblood is the
total volume of blood within both a single sinusoid and
the space of Disse.
Equations (3) and (5) are made dimensionless in the
axial direction by deﬁning the following variables:
n¼

x
; s ¼ L=v
L

ð6Þ

Using the above variables, Eq. (3) can be written as
follows:
s

@Ci;blood
@Ci;blood
1 @ 2 Ci;blood
¼þ
- Ji;b-t s
@t
@n
Pei @n2

ð7Þ

where Pe is the Peclet number which is deﬁned as
Pei ¼

vL
Da;i

Using the parameter values given in Table 1, PeGLC
and PeLAC are calculated to be 200 and 142, respec
tively.
The boundary conditions are obtained by assuming
that the ﬂow of blood is plug ﬂow (i.e. no dispersion)
before entering and after leaving the sinusoids. These
are called Danckwert’s boundary conditions and rep
resent an open system. The corresponding boundary
conditions are given by18:
At x ¼ 0:

Ci;blood jx¼0 ¼ C1
i;blood þ

At x ¼ L :

@Ci;blood
¼0
@x

Da;i @Ci
v @x

ð8Þ

ð9Þ

The initial conditions depend upon the physio
logical state and will be discussed in the results
section.
Metabolic Pathway
Simpliﬁed pathways representing glycolysis, gluco
neogenesis, glycogenolysis, glycogen synthesis, citric
acid cycle, oxidative phosphorylation, triglyceride
breakdown, and fatty acid synthesis and degradation
were included (Fig. 4). Each of these pathways is rep
resented by 1–4 key reactions. The name of the reac
tion either corresponds to the enzyme name (when
representing a single reaction) or to the names of the
substrate and product (when representing a series of
reactions lumped together). Kinetic expressions are
given in Table 2. Reversible, near-equilibrium reac
tions ðRGAP!PEP ; RLAC!PYR Þ are represented by a
simpliﬁed form of a reversible, ping-pong mechanism.
All other reactions are assumed to be essentially irre
versible and are represented by Michaelis–Menten ki
netic expressions with modulation by CADP/CATP and
CNADH/CNAD + as relevant. The ﬂux through the ci
tric acid cycle was assumed to exist in an additive
‘‘ping-pong’’ relationship.61
Kinetic parameters were estimated from concen
tration and ﬂux data measured at the overnight fasted,
resting state. The input and output ﬂuxes at steady
state were estimated from a combination of in vivo
experiments on humans and dogs and internal ﬂuxes
were then calculated using ﬂux balance analysis (FBA).
Species concentrations were compiled mostly from
experiments with overnight fasted rats. The set of
experimental and calculated ﬂuxes and concentrations
are shown in Tables 2 and 3. In the case of irreversible
reactions, the Km in each reaction was set equal to the
experimental substrate concentration at steady state,
the Km for CADP/CATP, represented by PSi, was set
equal to the steady state experimental CADP/CATP
ratio, and the Km for CNADH/CNAD+, represented by
RSi, was set equal to the experimental CNADH/CNAD+
ratio, all measured in animals following an overnight
fast. From these parameter values and concentration
and ﬂux values, the Vmax’s were calculated uniquely
using the kinetic expressions. Reversible reactions were
handled differently. In general, the Vmax’s and Keq’s
were determined from in vitro measurements, and then
the Km’s were calculated such that the net ﬂux through
the reaction matched the experimental (or FBAcalculated) ﬂux. The Haldane equation (relating
kinetic parameter values at near-equilibrium) was used
to reduce the number of unknown parameters and to
ensure consistency with thermodynamic constraints. If
no kinetic expression is given, then that ﬂux was

Glucose
ATP

GK

G6Pase

ADP
Glyphos

G6P
ATP

NADH

Glycogen

NAD+

ADP

ATP

ADP

GAP
ADP + NAD

+

GR3P
GR3 P

Glycerol
TGL

+

ADP + NAD

ADP
AD
ATP + NADH

ATP + NADH

ATP

Fatty ac
acids

PEP
PEP
ADP
AD

PK

ADP
AD

NAD+

ATP
AT
P

PEPCK

PYR
PY
ATP

+

ADP
AD
NADH

NAD + ATP

ATP

NADH+ ADP
ADP

NADH

ALA
PC

Oxaloacetat
Oxaloacetate

NAD+
NADH
NAD +

CO2

ADP+NAD+

LDH

ADP

TCA

AcCoA

PDH

ATP

½ O2

ATP+NADH

OxPhos

H2 O

2.5ADP+NADH 2.5ATP+NAD+

Lactate

ATPase
ATP
AT

ADP
AD

FIGURE 4. Reaction network considered in tissue model. Arrows without enzyme names indicate a series of reactions that have
been lumped together. The ATPase reaction represents the total of all ATP-utilizing reactions that are not considered explicitly in
the model. GK: glucokinase; G6Pase: glucose-6-phosphatase; Glyphos: glycogen phosphorylase; OxPhos: oxidative phosphor
ylation, PK: pyruvate kinase; PC: pyruvate carboxylase; PEPCK: phosphoenylpyruvate carboxykinase; PDH: pyruvate dehydro
genase; LDH: lactate dehydrogenase; G6P: glucose-6-phosphate; GAP: glyceraldehyde-3-phosphate; GR3P: glycerol-3-phosphate;
PEP: phosphoenylpyruvate; AcCoA: acetyl CoA.

assigned a constant value in the model, given by either
the measured or calculated ﬂux.
The zonation phenomenon is incorporated into the
model by assuming either linear (Vmax = Vo,l + aÆ x/
L) or exponential (Vmax = Vo,eÆ exp(bÆ x/L) variations
in maximal activities for the reactions for which the
phenomenon has been observed. The parameter val
ues in these functions were determined by assuming
that the relative changes in maximal enzyme activities
between the periportal and perivenous regions are
similar to those reported in the literature (Table 3),
and that the maximal activities at x/L = 0.5 are gi
ven by the values in Table 2. The parameters used in
the functions for Vmax are given in Table 3 and the
functions are graphed in Fig. 5 (Table 4). The use of
exponential functions is based on the hypothesis that
substrate concentration gradients along the sinusoid
are most likely exponential (e.g. as measured for
pO2), which may inﬂuence the distribution of enzyme
activity. There is clear literature support for the
zonation of glucokinase (GK), glucose-6-phosphatase
(G6Pase), fructose-1,6-bis-phosphatase (represented
by Vmax;GAP!G6P ), phosphoenyl pyruvate carboxy
kinase (PEPCK), and pyruvate kinase (PK).
Although zonation of pyruvate carboxylase (PC) has
not been speciﬁcally reported, because of this

enzyme's key role in gluconeogenesis, the zonation of
Vmax,PC was included using a function similar to that
used for Vmax,PEPCK. Similarly, the results were cal
culated with zonation of phosphofructokinase (rep
resented by Vmax;G6P!GAP ) using a similar function to
that of GK. The incorporation of zonation of
Vmax, G6P ﬁ GAP did not change any of the ﬂux
proﬁles, except for that of VG6P!GAP itself (data not
shown), and thus does not seem to be essential. Al
though zonation is also known to occur in lipid
metabolism, this was not addressed in this work since
detailed lipid metabolism kinetics are not included in
the model.
The model consists of 13 mass balances: glucose in
blood and tissue (GLCb, GLCt), lactate in blood and
tissue (LACb, LACt), and in tissue only: glucose-6
phosphate (G6P), phosphoenolpyruvate (PEP), pyru
vate (PYR), AcCoA, oxaloacetate (OXA), ATP,
NADH, glycogen (GLY), glyceraldehyde-3-phosphate
(GAP). The quantities CNADH + CNAD+, CATP + 
CADP, and CPi are assumed to be constant, with values
given in Table 3.
The governing equations in the blood, which is a
partial diﬀerential equation for each species in the
blood, were converted to ordinary diﬀerential equa
tions by means of the ﬁnite diﬀerence method using

Table 2.

Fluxes, kinetic expressions and parameter values. (PS = CATP/CADP; RS = CNAD+/CNADH)

Rate

Flux used for parameter
estimation (lmol substrate
/gww.hep/min, unless
otherwise speciﬁed), derived
from either experimental
data (with reference given),
or calculated from ﬂux
balance analysis

RGK

0.136 (Shulman, et al.64)

0.14

RG6Pase

0.721*

0.717

Vmax;G6Pase CG6P
Km;G6Pase þCG6P

RGlyPhos
RG6P!GAP

0.304 lmole C6/gww/min55
0.136 lmole C6/gww/min
(Shulman et al.64)

0.134

Vmax;G6P GAP CG6P
Km;G6P GAP þCG6P

RGAP->G6P

0.83 lmole C3/gww/min*

0.815

Vmax;GAP G6P CGAP
Km;GAP G6P þC
( GAP

RPEP->GAP;net

0.472*

0.458

RGR3P->GAP
RPK

0.0888*;
(0.112 in Brundin et al.13)
0.94*

0.931

Vmax;pk CPEP
Km;PK þCPEP

RPC

1.416*

1.39

Vmax;PC CPYR
Km;PC þCPYR

RPEPCK

1.416

1.39

Vmax;PEPCK COXA
Km;PEPCK þCOXA

RPDH
RLAC->PYR;net

0.0 52
0.216*

0.201

Vmax;LDH
CPYR CNADH
Km;LAC PYR CLAC CNADþ - Keq;LDH
CLAC CNADþ CPYR CNADH
1þK
þ
m;LAC PYR Km;PYR LAC

RTCA -

0.78 lmole C2/gww/min*

0.78

44

Flux calculated
from simulation
(lmol substrate/
gww hep/min)

Kinetic expression
(
)
Vmax;GK CGLC t
1=PS
Km;GK þCGLC t 1=PSi þ1=PS

(

ROxPhos

2.11 lmole* O2/gww/min )

JGlc,b_t_net

)0.58513,9

JLAC,b_t_net

2.11

)

Vmax,G6P_GAP = 0.54

Vmax;PEP GAP
Km;PEP GAP

C
C C
C
CPEP CNADH CATP - GAPK Pi NADþ ADP
eq;PEP GAP
CPEP CNADH CATP CGAP CPi CNADþ CADP
1þ K
þ
Km;GAP PEP
m;PEP GAP

(

)
PS
PSi þPS
(
)
1=PS
1=PSi þ1=PS

(

)

1=PS
1=PSi þ1=PS

)

V(mzx;TCA ½AcCoA]
)
x e 1=RS1=RS
þ ð1 - eÞ 1=PS1=PS
i þ1=RS
i þ1=PS
(
)(
)
V
C
max;OxPhos

O2

Km;OxPhos þCO2

PS
PSþPSi

)0.577

Vmax;GLC;b t ðCGLC;b -CGLC;t Þ
Km;GLC;b t þðCGLC;b þCGLC;t Þ

0.21669

0.202

Vmax;LAC;b t ðCLAC;b -CLAC;t Þ
Km;LAC;b t þðCLAC;b þCLAC;t Þ

RGLR;blood->GLR;tissue
RATP->ADP

0.87 lmole C2/gww/min*
1.345 lmole z C2/gww/min
0.09 lmole C2/gww/min *
0.1152*
0.0264 lmole TG/gww/min *
0.0032 lmole TG/gww/min *
0.023 lmole TG/gww/min
(0.065 in Jensen36) z
0.11237
8.73*

8.29

Vmax;ATP ADP ð1=PSÞ
ð1=PSÞþKm;ATP ADP

RALA->PYR

0.25665

RFA->AcCoA
RFA;blood->FA;tissue
RAcCoA->FA
RGLR->GR3P
RGR3Pþ3FA->TG
RTG->GLRþ3FA
RTG;tissue->TG;blood

Vmax,GK = 0.54
KM,GK = 3.61
PSi = 0.45
Vmax,G6Pase = 1.41
Km,G6Pase = 0.06

1=PS
1=PSi þ1=PS

(

12

Parameter values
(Vmax in lmol/gww/min;
Km in lmol/gww)

RS
RSi þRS

)

Km,G6P_GAP = 0.06
Vmax,GAP_G6P = 1.60
Km,GAP_G6P = 0.0031
Vmax,PEP_GAP = 9416)
Km,PEP_GAP = 2.7x10)4
Km,GAP_PEP = 1.75x10)4
Keq,PEP_GAP = 416757)

Vmax,PK = 3.78
Km,PK = 0.046
Vmax,PC = 5.66
Km,PC = 0.059
Vmax,PEPCK = 5.66
Km,PEPCK = 0.0003
Vmax,LDH = 19516
Km,LAC_PYR = 1.19
Km,PYR_LAC = 2.29x10)7
Keq,LDH = 1.64x10)4 * *
Vmax,TCA = 15.62
e = 0.7561
Vmax,OxPhos = 16.9
Km,OxPhos = 7.33
Vmax,GLC,b\_t = 57.0
Km,GLC,b_t = 3.61
Vmax,LAC,b_t = 3.24
Km,LAC,b_t = 1.2

Vmax\_ATP\_ADP = 16.71
Km\_ATP\_ADP = 2.25

*Value calculated via Flux Balance Analysis (FBA).
z Some of the input/output ﬂuxes used deviate somewhat from experimental reports. Since this model is to be used in a model of the whole
body, the input and output ﬂuxes were required to be consistent with the overall balances in the body for species such of FA, TGL, Glc, ALA,
GLR, and LAC. GLR: glycerol; Glc: glucose; Gly: glycogen; LAC: lactate; OXA: oxaloacetate.
**Value calculated based on the Gibbs function data from Alberty, 20031

200 grid points. The governing equations in the tissue
were written for each species for each of the 200 grid
points. All ODE’s were then solved simultaneously
using the FORTRAN routine LSODE.
The sensitivities of concentration of species i (Ci)
and ﬂux i (Ri) to parameter Kj are deﬁned as:

Table 3 Species concentrations in liver tissue, at the over
night fasted state, used to estimate kinetic parameters. Units
are lmol gww)1 hep.
Species

Concentration used
to estimate parameters

Glc,tissue
Glc,blood
G6P
glycogen
GAP
GR3P
PEP
PYR
OXA
LAC,blood
LAC,tissue
AcCoA
Oxygen
ATP

Reference
Bergmeyer8
Bergman et al.7
Bergmeyer8
Petersen et al.55
Stubs et al.67
Bergmeyer8
Bergmeyer8
Stubbs et al.67
Bergmeyer8
Bergmeyer8
Krebs48
Bergmeyer8
Brundin et al.12
Gyorgy et al.30;
Morikawa et al.54;
Gannon et al.21;
Hultman et al.34;
Boesiger et al.11

3.61
3.5
0.06
391
0.0031
0.281
.046
0.059
0.0003
1.2
0.98
0.1
7.33
3.43

ATP+ADP
NADH+NAD+
NADH/NAD+
Pi

1.22
.0014
5.74

C1
LAC;blood ¼ 1:2 mM
The resulting ﬂuxes are nearly identical to the
experimental (Table 2) and the calculated concentra
tions agree closely with the experimental concentrations
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Pyruvate Kinase

1

@Ri =Ri
@Kj =Kj

Simulations were ﬁrst performed at the resting,
overnight fasted state, without zonation, and with
boundary conditions given by:

5.7

0

SRi;j ¼

RESULTS

Bergmeyer
Stubbs67
Morikawa et al.54;
Bode et al.10

Glucokinase

@Ci =Ci
;
@Kj =Kj

Partial derivatives were estimated by central ﬁnite
diﬀerences.
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FIGURE 5. Linear and exponential functions of Vmax as a function of distance along the sinusoid length. Functions are ﬁtted by
assuming that the Vmax (given in Table 2) occurs at x/L = 0.5, and using the ratio of maximal activities from periportal to perive
nous, derived from data found in the references in Table 4. Function parameters are given in Table 4. The dashed line is a linear ﬁt
to the data, solid line is exponential ﬁt.

Table 4. Literature sources for maximal enzyme activities in periportal and perivenous regions, and the parameters values used
in the linear (Vmax = Vo,l + aÆ x/L) or exponential (Vmax = Vo,eÆ exp(bÆ x/L) zonation functions.
Vo,l(lmol/g/min)

a(lmol/g/min)

Vo,e(lmol/g/min)

b(lmol/g/min)

0.17
1.87
2.70
2.33
8.54
8.54

0.74
)0.87
2.16
)1.33
)5.76
)5.76

0.27
2.46
2.83
2.50
9.52
9.52

1.39
)1.07
0.58
)0.81
)1.04
)1.04
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(not shown). Since these ﬂuxes and concentrations were
used to estimate the kinetic parameters, these results
indicate that the program and model are consistent
and do not constitute independent veriﬁcation of the
model.
The total glucose output and lactate uptake by the
liver in the fasted, resting state, calculated from Eq. (2)
and assuming constant Vmax’s, are shown in Fig. 6.
The simulated values for both glucose output and
lactate uptake are nearly identical to experimental
values. The incorporation of zonation, whether linear
or exponential, has no effect on the overall liver output, mainly because the functions used in zonation
were based on setting the Vmax (at x/L = 0.5) equal
to the constant Vmax used in the ‘‘no zonation’’
simulation.
The net glucose production and lactate uptake rates
along the sinusoid length are shown in Fig. 7. As
shown in Fig. 7a (with no zonation), the net glucose
and lactate ﬂuxes are essentially constant along the
length of the sinusoid, indicating that at the relatively
high blood velocities (and therefore Pe), the species
concentration gradients in the axial direction are
minimal, causing little variations in ﬂuxes. Fig
ures 7(b–g) show the results from simulations where a
single enzyme has its Vmax as a function of distance.
These results indicate that PK, F1,6BPase (represented
by GAP ﬁ G6P), and PC have the greatest inﬂuence
on spatial variation in glucose and lactate ﬂuxes. With
zonation of all six reactions (Fig. 7h), synergistic
effects are observed with a 35% decrease in glucose
production between periportal and perivenous regions,
and with lactate ﬂux changing from uptake (in peri
portal) to production in the perivenous region.
Experimental values36 of net glucose production from
microdissected liver tissue and from cultured hepato
cytes stimulated to represent either periportal or peri
venous cells are shown in Fig. 7h. While the magnitude
of change between periportal and perivenous was
greater in the experiments than the simulations, the
simulations do show the expected trend. Furthermore,
there is signiﬁcant uncertainty in the experimental
data. For instance, the data from the liver tissue are

6P

Jungermann et al.
Katz et al.45
Matsumura et al.53
Guder and Schmidt29; Jungermann40
Guder and Schmidt29; Matsumura et al.53

G

42

mol/min/person

Vmax,GK
Vmax,G6Pase
Vmax;GAP!G6P
Vmax,PK
Vmax,PEPCK
Vmax,PC

Reference

mol/min/person

Reaction

FIGURE 6. (a) Net glucose production by the liver and (b) net
lactate uptake by the liver at the fasted, resting state, using
blood ﬂow = 1.47 l/min and parameters given in Tables 1 and
2. Results are shown for both exponential and linear zonation
functions. Results were calculated using a single enzyme with
a zonation function, then with zonation in all six enzymes
simultaneously, and also with no zonation (i.e. constant
Vmax’s). Experimental data from the literature are shown for
comparison.

actually calculated from measurements of maximal
enzyme activities and substrate concentrations from
the tissue extracts, and assuming Michaelis–Menten
kinetics, so there is signiﬁcant room for error there.
Secondly, the cultured hepatocyte system is, at best, an
approximation of the two regions of the liver paren
chyma in vivo.
The ﬂuxes through each of these six reactions (cal
culated with zonation in all six reactions, compared to
no zonation) are shown in Fig. 8, after normalization
to the ﬂux at x/L = 0. Again, ﬂuxes in each reaction
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FIGURE 7. Net rates of glucose production, JGLC;t!b;net and lactate uptake JLAC;b!t;net by the tissue along the length of the
sinusoid, in fasted, resting condition. (a) no zonation; (b)–(g) with zonation only for the enzyme indicated in the graph title, with all
other enzymes having constant activity; solid line: linear zonation; dotted line: exponential zonation; (h) zonation of all six
enzymes simultaneously, compared with experimental data from Jungermann;37 solid line: linear zonation function; dotted line:
exponential zonation function; h: tissue extracts from periportal (shown at x/L = 0) and perivenous (shown at x/L = 1) zones of
microdissected rat liver parenchyma, with ﬂuxes calculated from measured local enzyme activities and substrate concentrations
and assuming Michaelis-Menten kinetics; O: measured in cultured hepatocytes that have been stimulated to resemble either
periportal (shown at x/L = 0) or perivenous (shown at x/L = 1) cells, and placed in media representing the fasted state.

are nearly constant along the length when there is no
zonation, indicating that there is little effect of poten
tial concentration gradients on ﬂux distributions. The
axial variations become much more signiﬁcant with the
incorporation of enzyme zonation, with the glycolytic
ﬂuxes (GK, PK) increasing with distance and the glu
coneogenic ﬂuxes (G6Pase, F1,6BPase, PEPCK, PC)
decreasing. For example, the calculated glucokinase
ﬂux, with zonation, increases 6-fold between periportal
(x/L = 0) and perivenous (x/L = 1). This result is
identical to the 6-fold increase in glycolytic ﬂux mea
sured in periportal-like vs. perivenous-like hepato
cytes.38 On the other hand, the calculated G6Pase ﬂux

decreases between periportal and perivenous, but to a
much lesser extent than that reported by Jungerman
(5% decrease in calculated value, compared to 48%
decrease in measured gluconeogenic ﬂux). The G6Pase
reaction ﬂux does not change as signiﬁcantly as the
maximal activity for G6Pase (Fig. 5), since the ﬂux is
tempered by the substrate concentration and the rela
tively large blood ﬂow rate in the liver.
The parameter sensitivities were calculated using the
model without zonation representing the fasted, resting
state. The sensitivities of overall glucose production
(PGLC) and lactate uptake (PLAC) relative to the kinetic
parameters are shown in Fig. 9. The lactate uptake is
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FIGURE 8. Reaction ﬂuxes as a function of sinusoid length, during the fasted, resting state, with zonation of all six reactions, and
without zonation. Fluxes are normalized to the ﬂux value at x/L = 0. Lines represent simulations, open circles represent experi
mental data from cultured hepatocytes, stimulated to resemble either periportal (shown at x/L = 0) or perivenous (shown at x/L = 1)
cells, and placed in media representing the fasted state, from Jungerman, 1983.

much more sensitive to parameters than the glucose
output, since the glucose output is a function of both
glycogen degradation (which is set to a constant) as
well as the lactate uptake and intermediary reactions.
Not surprisingly, the ﬂuxes are most sensitive to
parameters in some of the key regulatory reactions,
such as PK, PC, and F1,6BPase (represented by
GAP ﬁ G6P). Also note that the sensitivity to the
parameters related to nonspeciﬁc ATP demand is also
relatively high. But for all parameters, the sensitivities
of overall glucose output and lactate uptake are less

Absolute Value of Sensitivity

1.0

than one, indicating that the results are stable and that
no single parameter has an ampliﬁcation effect on the
overall ﬂuxes.
The sensitivities for all internal ﬂuxes and species
concentrations are shown in Tables A.1 and A.2. In
general, concentrations and ﬂuxes were more sensitive to
Vmax’s than to Km’s, indicating the importance of having
good estimates especially for the Vmax’s. The Vmax’s cor
responding to gluconeogenic reactions were most inﬂu
ential, i.e. G6Pase, PC, GAP ﬁ G6P, and PK (which
affects the amount of cycling during gluconeogenesis).
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FIGURE 9. Absolute values of the sensitivities of net overall glucose production (SPGLC,j) and lactate uptake (SPLAC,j) to kinetic
parameters j, given in the x-axis.

The most inﬂuential Km is Km,ATP_ADP, which appears in
the nonspeciﬁc ATP usage kinetic expression. This
parameter does not have direct physiological signiﬁcance,
and thus an experimental value is unavailable. The
transport parameters had relatively little effect on the
results, indicating that the system is more metabolically
driven rather than transport driven.
The sensitivities of all the ﬂuxes to all the parame
ters are all less than one, indicating that there were no
cases of disproportionate eﬀects of parameters on ﬂux
distributions. On the other hand, the OXA concen
tration was hypersensitive to Vmax,PEPCK, Vmax,PC,
Vmax,ATP_ADP, and to a less extent, Vmax,OxPhos. This
results from the low in vivo concentration of OXA
(0.0003lmol/g/ww).
The model, without zonation, was modiﬁed to
account for physiological changes during high-inten

sity exercise (0.195 kW), and the overall calculated
glucose output and lactate uptake rates were com
pared to experimental values. Figure 10 contains
simulation results representing the resting state and
quasi-steady state at 20 min of exercise. During
longer periods of exercise many other physiological
changes occur which are not represented in the
model. It is known that blood ﬂow through the liver
decreases by about 50%69 during high intensity exer
cise as nutrients and oxygen are diverted to the heart
and muscle tissue. The results in Fig. 10(ii) indicate
that a 50% decrease in blood ﬂow rate alone has
negligible effect on glucose production and lactate
uptake, and thus is not sufﬁcient modiﬁcation of the
model to represent exercise. According to Wahren,69
arterial lactate concentration increases 5-fold in
humans during exercise, and assuming negligible
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FIGURE 10. Net glucose production and lactate uptake by the liver, calculated at quasi-steady state at 20 min following transition
from resting to high-intensity exercise. i) Resting, overnight fasted state (i.e. initial condition); ii) liver blood ﬂow rate decreased by
1
parameters as in (ii), plus: 5-fold increase in lactate concentration in the combined hepatic artery/portal vein input to the
2; iii) same
liver (C¥LAC,blood) to 6.0 mM; iv) same parameters as in (iii), plus: 3-fold increase in glycerol uptake, to 0.51 umol/g/min, increase in
glycogen breakdown to 2.2 umol/g/min, and 3-fold increase in alanine uptake; v) same changes as in (iv), plus: changes in Vmax of
GK, G6Pase, PFK, PC, and PEPCK resulting from the decrease in insulin concentration and increase in glucagon during exercise;
vi) measured value at high intensity exercise.69

lactate uptake in the gut, the value for C¥LAC,blood
was increased 5-fold to 6.0 mM. Figure 10(iii) shows
that this increase in lactate concentration also has
negligible effect on glucose output, although lactate
uptake does increase by 30%. Glycerol uptake rate
was then increased 3-fold and the glycogen degrada
tion rate was increased to 2.2 umol/g/min, based on
measurements in humans by,69 and amino acid up
take (represented by alanine uptake) was increased 3
fold.71 These ﬂuxes are assumed to be constant over
the 20-min simulation period. The incorporation of
these changes into the model causes a doubling of
hepatic glucose production (Fig. 10iv), but the chan
ges are still not enough to account for the 5-fold in
crease in observed glucose output during exercise.69
Lactate uptake actually becomes negative, which is an
unrealistic resulting indicating that there is a bottle
neck in the gluconeogenic reactions that keeps the
extra substrate from exiting the tissue as glucose.
It is known that exercise causes a 28% decrease in
arterial insulin concentration,69,70 which is already low
because of the fasting state; more speciﬁcally, a 37%
decrease occurs at high intensity exercise.69 Exercise
also causes an increase in glucagon concentra
tion,70,32). Additionally, the increased adrenergic
activity during exercise causes an increase in adrena
line, noradrenaline,17 and epinephrine.32 The insulin
decrease and glucagon increase, together, cause the
maximal enzyme activity of PK to decrease35, and
of G6Pase,3 PEPCK and F1,6 bisphosphatase to
increase 35. Glucagon induces the inhibition of PFK
and PK via short-term allosteric action35, while insulin
acts conversely. Glucagon also induces PEPCK and
F1,6bisphosphatase activity over the long-term via
gene expression, with inverse action by insulin. Simu
lations by El-Refai and Bergman (1976) have also
suggested that the maximal activity of GK increases
100% upon insulin stimulation.
The hormonal changes during exercise described in
the previous paragraph were incorporated into the
model by decreasing Vmax,GK and Vmax;G6P!GAP by
50%, increasing Vmax,G6Pase 2-fold, and increasing
Vmax,PC and Vmax,PEPCK 2 12-fold immediately upon
switching to the high-exercise state. As shown in
Fig. 10(v), these changes cause a 4-fold increase in
hepatic glucose production, which compares favorably
with experimental values (Fig. 10vi). Calculated lactate
uptake also increases, matching the experimental
value.

DISCUSSION
A model of reaction and transport in the liver was
developed that can describe the metabolite concen

tration and reaction ﬂux dynamics separately within
the tissue and blood domains. The blood domain
contains equations for convection, axial dispersion,
and transport to the surrounding tissue; and the tissue
domain consists of reactions representing key pro
cesses of glycolysis, gluconeogenesis, glycogenolysis,
tricarboxylic acid cycle, oxidative phosphorylation,
and fatty acid degradation and synthesis. The model
includes the metabolic heterogeneity of the liver by
incorporating spatial variation of key enzymatic
maximal activities.
This model builds upon and integrates information
from previous models of liver metabolism that have
focused on either subsets of reactions, have included
comprehensive set of metabolic pathways assuming
well-mixed tissue, or have described the heterogenous
nature of the liver in terms of a single species or
reaction. Furthermore, the kinetic parameters and the
data used for validation were based for the most part
on human data, and to a lesser extent, on in vivo
experiments with dogs or in vitro experiments with
rats. We believe that this emphasis on use of in vivo
data to obtain kinetic parameters circumvents the
common criticism of complex models that use kinetic
parameters that have been measured in environments
that are very different from the intact system. Given
that, there is still considerable uncertainty in param
eter values, and assumptions made about Km values
then affected the values of Vmax’s needed to be con
sistent with the in vivo data. Fortunately, our sensi
tivity analysis showed that the results were much less
sensitive to the selection of Km’s than to Vmax’s, and
the Vmax’s that were most inﬂuential belong to the
regulatory reactions in glycolysis and gluconeogene
sis, for which there is substantial availability of in
vitro experimental data. The kinetic parameters of the
ATPase reaction also were among the most inﬂuen
tial. Since this reaction represents many ATP-using
reactions and the parameters have no direct physio
logical meaning, it may be better to consider this
reaction ﬂux as an adjustable parameter that has
upper and lower limits derived from in vivo ﬂux bal
ance analysis.
Simulation results at the overnight fasted, resting
state agree closely with experimental values of ﬂuxes
and concentrations, and overall glucose uptake and
lactate output are conﬁrmed with independent data.
The incorporation of zonation of glycolytic and glu
coneogenic enzyme activities causes the expected
increase in glycolysis and decrease in gluconeogenesis
along the sinusoid length. The results from simula
tions with and without zonation indicate that trans
port gradients are not suﬃcient to account for
observed axial variations in gluconeogenesis and gly
colysis, and that a distributed-in-space arrangement

of enzyme activities is necessary to achieve this result.
By incorporating the zonation of each enzyme sepa
rately in the model, we could ascertain the impor
tance of each enzyme to the axial variation in glucose
and lactate ﬂuxes. While several enzymes were more
inﬂuential, e.g. PK, F1,6BPase (represented by
RGAP!G6P ), and PC, no single enzyme alone with
zonation caused a signiﬁcant axial variation in ﬂuxes.
The zonation of all reactions combined served to in
crease the axial variations of glucose and lactate
ﬂuxes.
The physical causes of zonation, whether resulting
from hormonal or oxygen gradients or diﬀerential
innervation, as have been hypothesized38 have not
been addressed in this work. While substantial
evidence exists that enzymes of the fatty acid metabolic
pathways also exhibit distributed activities,40,6 the
analysis of enzymatic zonation presented here is
strictly limited to the central carbohydrate pathways.
The model results are based on the assumption that
the sinusoids are structured in parallel, and have uni
form size and velocity. In reality, there is signiﬁcant
variation in both length and blood velocity, with a
fraction of the sinusoids switching between having ﬂow
and no ﬂow at any one time51. Moreover, there is
branching in some of the sinusoids, and some of the
hepatic arterioles and portal venules may connect with
the sinusoid at up to a third of the distance down the
sinusoid. The effects of this complicated ﬂow pattern
and structure on the simulated metabolic results pre
sented here are non-obvious, and will be the subject of
a future study.
During high-intensity exercise, the hepatic glucose
production in humans increases nearly 5-fold, with a
smaller increase in lactate uptake. The simulations
shown here indicate that observed changes in arterial
substrate concentrations and hepatic blood ﬂow rate
are not suﬃcient to shift the liver metabolism enough
to account for this increased glucose output. Changes
in gluconeogenic and glycolytic enzyme activities,
whether caused by exercise-induced changes in insu
lin, glucagon, adrenaline, noradrenaline, or epineph
rine, or even by direct adrenergic stimulation of the
liver are needed to achieve the overall metabolic
changes observed. The amounts of induction or
inhibition of enzymatic activities that were incorpo
rated into the model were based on extrapolation
from information from the literature. The simulations
have shown that hormonal eﬀects on all the reactions
analyzed are crucial for the physiologically realistic
response of the liver to exercise, and changes in

individual enzyme activities (data not shown) were
not suﬃcient to achieve this.
The changes in hormone concentrations, and the
subsequent changes in enzyme activities, do not oc
cur immediately at the onset of exercise. Since these
changes in enzyme activities were incorporated in the
model at the onset of exercise, the simulated tran
sients are unrealistically fast (not shown), and thus
only the steady state simulation results representing
the physiological conditions expected at about
20 min of exercise were presented here. Several
modiﬁcations to the model are needed to generate
more realistic dynamics. Mass balance equations of
hormones, especially insulin and glucagon, with up
stream arterial concentrations that vary with time
according to available experimental data, need to be
added to the system. The inﬂuence of hormones will
be especially visible in the distributed model, since
hormone degradation occurs within the liver and
signiﬁcant gradients in hormone concentrations occur
along the sinusoid length39. The allosteric effects on
enzyme activity by the relevant local hormone con
centrations (most likely the glucagon/insulin ratio),
mediated by cAMP and phosphorylation or
dephosphorylation reactions, need to be accounted
for in the appropriate kinetic expressions. These
changes can be expected to result in a more gradual
response to the onset of exercise as well as to
changes in dietary conditions.
Simulations were performed based on the fasted
state, which is the condition under which many of the
human exercise studies are performed. Since relatively
simple kinetic expressions were used in the model, the
response to exercise in the fed state will not closely
match experimental data. Incorporation of allosteric
regulatory mechanisms into the key reactions in gly
colysis and gluconeogenesis will result in a more ro
bust model that is valid under a variety of nutritional
states.
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)1.0E)01 2.0E)02 0.0E + 00 )7.6E)03 8.6E)02 4.3E)05
0.0E + 00 0.0E + 00 0.0E + 00 0.0E + 00 0.0E + 00 0.0E + 00
0.0E + 00 0.0E + 00 0.0E + 00 0.0E + 00 0.0E + 00 )6.3E)06
)7.0E)01 1.8E)01 0.0E + 00 )2.4E)02 7.9E)01 2.8E)04
2.8E)01 1.4E)01 0.0E + 00 1.4E)01 6.1E)01 2.9E)04
2.8E)01 1.4E)01 0.0E + 00 1.4E)01 6.1E)01 3.0E)04
)1.1E)01 )1.3E)02 0.0E + 00 )2.8E)02 )5.3E)02 )3.0E)05
)2.1E)01 4.1E)02 0.0E + 00 )1.5E)02 1.8E)01 7.9E)05
)3.1E)01 8.0E)02 0.0E + 00 )1.1E)02 3.5E)01 1.6E)04
)9.8E)03 )3.2E)02 0.0E + 00 )2.1E)02 )1.4E)01 )6.9E)05
)1.2E)01 3.2E)02 0.0E + 00 )4.2E)03 1.4E)01 6.2E)05
)7.0E)01 1.8E)01 0.0E + 00 )2.4E)02 7.9E)01 2.5E)04

Vmax,G6Pase Vmax,G6P_GAP Vmax,PK

GlCblood
)4.9E)04 4.6E)03
)6.9E)04 6.4E)03
GlCtissue
3.4E)03 )2.4E)02
LACblood
1.2E)02 )8.3E)02
LACtissue
G6P
2.0E)01 )9.5E+00
GLY
0.0E + 00 0.0E + 00
ATP
)5.5E)03 1.1E)02
NADH
)1.6E)02 3.6E)02
PYR
5.1E)02 )2.7E)01
AcCoA
)8.2E)03 1.8E)02
PEP
4.4E)02 )4.3E)01
OXA
5.1E)02 )2.7E)01
GAP
2.5E)02 )4.9E)01
GK
4.3E)01 2.2E)02
PK
3.0E)02 )2.2E)01
G6Pase
7.8E)02 5.5E)02
TCA
0.0E + 00 )3.4E)06
OxPhos
0.0E + 00 )1.9E)05
LDH
)3.9E)02 2.7E)01
PC
1.5E)02 )1.1E)01
PEPCK
1.5E)02 )1.1E)01
G6P_GAP 6.7E)02 )8.9E)01
GAP_G6P 1.2E)02 )2.2E)01
PEP_GAP )1.7E)02 1.2E)01
ATPase
)8.9E)03 1.9E)02
Glc,b_t_net )6.9E)03 6.4E)02
LAC,b_t,net )3.9E)02 2.7E)01

Vmax,GK

Table A. 2 Sensitivity coefﬁcients to V's, deﬁned by Eq. (10). Values in boldface have magnitude greater than 0.50.
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